Exact Sciences Corporation (NASDAQ: EXAS)became one of the best-performing stocks of 2017. A successful marketing blitz helped test volumes soar, and they're still climbing. Now that Cologuard's launch trajectory appears to be tapering off, though, the shares have been bouncing around as nervous investors begin to worry the company might never turn a profit.
Where Will Exact Sciences Corporation Be in 5 Years?
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться